| Document |
Document Title |
|
JP5266499B2 |
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; catalyst comprises a copper atom or ion, ...
|
|
JP2013133377A |
To provide a new macro azo compound, a precursor and a production method thereof.The macro azo compound is represented by general formula (I) (wherein X is O or NH, each of R1 and R2 is CN or a 1-4C alkyl group, R3 is a 1-3C alkylene gro...
|
|
JP2013527837A |
[Subject] The manufacturing method of the poly (ethersulfone * imide or * amide) copolymer using annular oligomer is provided. [Means for Solution] A manufacturing method of the poly (ethersulfone * imide or * amide) copolymer by the pre...
|
|
JP5196788B2 |
|
|
JP2013513567A |
The invention in this application includes various opposite-sex objects which were not known until now in the first place, PF1022*V, PF1022*W which are cyclo オクタデプシ peptide of 24 members, XRB*C894, XRB*C942, XRB*C976, XRB*C10...
|
|
JP2013508323A |
The present invention relates to those use as the new amide compound of formula I, anti-tumor nature, and an apoptosis promotion medicine manufacture agent. The present invention contains the medicine constituent in which cancer and also...
|
|
JP2013040180A |
To provide a wide range of copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds, wherein inexpensive copper is used as a catalyst.For example, this invention relates to reaction methods shown by the following figure an...
|
|
JP5139999B2 |
|
|
JP5133027B2 |
|
|
JP2013014628A |
To provide heterocyclic aspartyl protease inhibitors, pharmaceutical compositions comprising the compounds, their use in the treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, and their use as inhibitors of t...
|
|
JP5117858B2 |
|
|
JP5078619B2 |
|
|
JP5061138B2 |
|
|
JP2012525357A |
The present invention discloses new catalyst systems based on complexes of divalent metals supported by chelating phenoxy ligands for immortal ring-opening polymerisation of cyclic esters and cyclic carbonates.
|
|
JPWO2010119906A |
Offer general formula (1) of a new weed killer : (化 1)The inside of [type and Z are *C (R).9) (R10* or *N (R)11Expressing *, A is an oxygen atom, a sulfur atom, or *N (R).12* is expressed, W expresses an oxygen atom or a sulfur atom, m...
|
|
JPWO2010119906A1 |
新規除草剤の提供一般式（１）：（化１）〔
式中、Ｚは−Ｃ（Ｒ9）（Ｒ10）−又は−Ｎ（
Ｒ11）−を表し、Ａは酸素原子、硫黄原子又
−Ｎ（Ｒ12）−を表し、Ｗは酸素原子...
|
|
JP2012522746A |
By the present invention, a method of ジメチル-izing of an active methylene group is indicated. Specifically, a method for preparing 3* amino *2 and 2* ジメチル propane amide is indicated by the present invention. Compounds, such...
|
|
JP5025652B2 |
|
|
JP2012520324A |
The present invention relates to the compound shown with the following structural formula, or its salt which can be permitted in medicine manufacture. The directions for a medicine constituent and the above-mentioned compound are also in...
|
|
JP2012167067A |
To clarify a molecular structure of a metal salen complex exhibiting a pharmacological effect, and to provide a metal salen complex including such a molecular structure, as well as a derivative of the complex.This metal salen complex com...
|
|
JP5020441B2 |
|
|
JP2012519717A |
This application is related with the new Karkar Bon acid which has the aza-heterocyclic moiety structure of oxo substitution at the disposal of the disease and/or the use in prevention, and the use in the manufacture of the medicine the ...
|
|
JP5014978B2 |
|
|
JP5004075B2 |
To provide a new cyclic ether amide lipid constructing molecular aggregates by self-organization, and a lipid membrane forming a moderate intramolecular hydrogen bond. This new cyclic ether amide lipid of 2 glycerol derivatives and 2 lon...
|
|
JP4968845B2 |
|
|
JPWO2010071213A1 |
The object of the present invention contains polyester and there is in providing the stinking resin composition with the isocyanate compound of isolation as for which a thing is not. The present invention is a resin composition containin...
|
|
JPWO2010071211A1 |
本発明の目的は、高分子化合物の末端封止剤
として有用な環状カルボジイミド化合物を提
供することにある。本発明は、下記式（ｉ）
で表される環状カルボジイミド化合物で...
|
|
JPWO2010071212A |
The object of the present invention does not separate an isocyanate compound and there is in providing the method of closing the end of polymer with a カルボ diimide compound. The present invention is the method of using a compound in...
|
|
JPWO2010071212A1 |
本発明の目的は、イソシアネート化合物を遊
離させず、カルボジイミド化合物により、ポ
リマーの末端を封止する方法を提供すること
にある。本発明は、カルボジイミド基を...
|
|
JPWO2010071211A |
The object of the present invention is to provide an annular カルボ diimide compound useful as an end closure agent of a high molecular compound. The present invention is an annular カルボ diimide compound denoted by following form...
|
|
JPWO2010071213A |
The object of the present invention contains polyester and there is in providing the stinking resin composition with the isocyanate compound of isolation as for which a thing is not. The present invention is a resin composition containin...
|
|
JP2012067103A |
To provide a new compound which is useful for treatment of Vancomycin-resistant bacteria infection.Following compounds are illustrated as new peptoid compounds, namely, methyl(2S, 5S, 8R/S)-8-acetamide-2-allyl-9-[6-allyl-9-t-butoxycarbon...
|
|
JP4897170B2 |
|
|
JP4885067B2 |
The present invention relates to compounds of the formula Q is selected from the group consisting of G is selected from the group consisting of alkyl, substituted alkyl, substituted or unsubstituted aryl, heterocyclo, W is O or NR15; X i...
|
|
JP2012012493A |
To provide an liquid crystal aligning agent, by which a liquid crystal alignment film can be obtained which has resistance to peeling and grinding when the alignment film is rubbed, has excellent liquid crystal aligning ability, has high...
|
|
JP4854853B2 |
|
|
JP2012001484A |
To provide a cyclic carbodiimide compound useful as a terminal blocking agent for a polymer compound.The cyclic carbodiimide compound is represented by formula (i). In formula (i), X represents a specific divalent group; and Ar1 and Ar2 ...
|
|
JP2011256139A |
To provide a cyclic carbodiimide compound useful as a terminal blocking agent for a polymer compound.The cyclic carbodiimide compound is represented by formula (i) (in the formula, X represents a specific divalent group or a specific qua...
|
|
JP2011251967A |
To provide an intermediate for cyclic carbodiimide compounds.There is provided a compound expressed by formula (s), wherein X represents an alkylene group, a phenylene group or a divalent group represented by formula (i-3).
|
|
JP4824668B2 |
|
|
JP4795242B2 |
|
|
JP2011526265A |
The present invention relates to the use of nifurtimox for the treatment of giardiosis, in particular in dogs and cats.
|
|
JP2011195720A |
To provide a curing agent capable of efficiently curing an aqueous resin containing a carboxyl group or an organic solvent resin.The curing agent comprises a carbodiimide compound (B) represented by the general formula as a curing compon...
|
|
JP2011178837A |
To provide an acid-trapping agent which is high in compatibility with resins, has little adverse effects to the resins, and has an ability for trapping not only an acid component produced by the decomposition of a resin itself but also a...
|
|
JP2011173840A |
To provide a new compound which varies optical rotation by irradiation with light.The optically active compound is represented by formula (1) (wherein X is each independently -NH2, -N(CH3)2, -H, -F, -I, -Br, -Cl, -COOH or the like; and a...
|
|
JP4748912B2 |
|
|
JP4743382B2 |
|
|
JP2011144318A |
To provide a resin material preventing a liberation of an isocyanate group-containing compound, having an advantageous working environment and an excellent hydrolysis resistance, and applying a small amount of burden on the environment.T...
|
|
JP2011521981A |
The invention relates to compounds of the formula (I) which are inhibitors of activated thrombin-activable fibrinolysis inhibitor. The compounds of the formula I are suitable for producing medicaments for prophylaxis, secondary preventio...
|
|
JP4734656B2 |
|
